MYD88 and colitis: Reishi has been shown to reduce AOM/DSS-induced colitis and tumourigenesis by inhibiting the TLR4/MyD88/NF-κB pathway, improving intestinal flora dysbiosis, and increasing the production of short-chain fatty acids (Guo et al., 2021).